The Ministry of Trade, Industry and Resources (MOTIR, Minister Kim Jung-kwan), the Ministry of Science and ICT (MSIT, Deputy Prime Minister and Minister Bae Kyung-hoon), the Ministry of Health and Welfare (MOHW, Minister Jeong Eun Kyeong), and the Ministry of Food and Drug Safety (MFDS, Minister Oh Yu-kyoung) announced plans to launch the second phase of the Inter-Ministerial Advanced Medical Device R&D Program, investing a total of KRW 940.8 billion (KRW 838.3 billion in government funding and KRW 102.5 billion in private investment) over seven years from 2026 to 2032.
The program aims to develop six game-changing medical devices that are world-first or world-leading and to localize 13 essential medical devices. This inter-ministerial initiative will support the entire R&D cycle—from basic and fundamental research to commercialization, clinical trials, and regulatory approval. In particular, it will focus on future growth areas such as AI- and robotics-based medical devices, strengthening global competitiveness and fostering the medical device industry as a national growth engine.
Building on the success of the first-phase Inter-Ministerial Full-Cycle Medical Device R&D Program (2020–2024), the new initiative passed the preliminary feasibility study for national R&D programs in August 2025. During the first phase, a total of 467 projects were supported, resulting in 433 regulatory approvals (331 domestic and 102 overseas), 72 technology transfers, and 254 cases of commercialization over the past five years. Notable achievements include the localization of hemodialysis filters, previously fully imported, and the development of the world’s first AI-based stroke diagnostic-assistance software medical device. The government plans to continue full-cycle R&D support through this follow-up program to ensure these achievements are sustained.
To that end, the four ministries held a joint briefing session on Wednesday, November 5, at the President Hotel in Jung-gu, Seoul, to present details of the program’s second phase. The session aimed to improve understanding among researchers from industry, academia, research institutes, and medical institutions and to encourage active participation. It covered the program’s main features, participation guidelines for 2026 projects, and key schedules, followed by a Q&A session and on-site feedback.
The government emphasized that this initiative is a cross-ministerial collaboration to support the development of advanced medical devices as a national growth driver and reaffirmed its commitment to ongoing communication with researchers to reflect their input and ensure the program’s successful implementation.